Log In
BCIQ
Print this Print this
 

PDS0101

  Manage Alerts
Collapse Summary General Information
Company PDS Biotechnology Corp.
Description2-component vaccine of nanoparticles that combine a biodegradable lipid enantiomer with HPV-peptide nanoparticles
Molecular Target
Mechanism of ActionImmunotherapy
Therapeutic ModalityPreventive vaccine: Peptide vaccine
Latest Stage of DevelopmentPhase I
Standard Indication Cancer (unspecified)
Indication DetailsTreat and prevent human papillomavirus (HPV)-related cancer; Treat cervical intraepithelial neoplasia (CIN)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today